Omnicell, Inc. (FRA:OC9)

Market Cap	1.53B -22.3%
Revenue (ttm)	1.01B +6.5%
Net Income	1.75M -83.6%
EPS	0.03 -85.2%
Shares Out	n/a
PE Ratio	877.47
Forward PE	22.94
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	32.60
Previous Close	32.60
Day's Range	32.60 - 34.00
52-Week Range	21.60 - 43.80
Beta	n/a
RSI	44.49
Earnings Date	Feb 5, 2026

About Omnicell

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy disp...

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1992
• Employees: 3,600
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OC9

Financial Performance

In 2025, Omnicell's revenue was $1.18 billion, an increase of 6.53% compared to the previous year's $1.11 billion. Earnings were $2.05 million, a decrease of -83.62%.

Financial numbers in USD